Abstract
Helminth (worm) infections are major public health problems that have important socioeconomic consequences for the more than 2 billion infected individuals. Chronicity (their hallmark) can lead to anemia (in hookworm infection), river blindness (onchcerciasis), cirrhosis (schistosomiasis), and elephantiasis (lymphatic filariasis). Although there have been many studies examining innate immune responses (including TLR expression and function) in response to intracellular pathogens, fewer have examined the interaction of the multicellular helminth parasites and the innate immune system. This review will focus on two “systemic” helminth parasitic infections (lymphatic filariasis and schistosomiasis) and the regulation of TLRs that may contribute to infection outcome.
Similar content being viewed by others
Introduction
Helminth infections are a major public health problem resulting in many physical disabilities and having important socioeconomic impact. Helminth parasites have developed mechanisms to evade host responses allowing them to survive in hostile environments such as the gastrointestinal tract, the lymphatics, and the bloodstream [1].
Almost 130 million people are estimated to be infected by one of three parasites causing lymphatic filariasis in humans: Wuchereria bancrofti, Brugia malayi, and Brugia timori [2]. The infection is initiated by third-stage larvae (L3) deposited in the skin after a mosquito bite. With development of L3 to L4 and then to adult worms, the parasite evades the primary line of defense at the skin site and migrates to the lymphatics, where adult parasites reside and, when mature, release microfilariae (MF), a stage felt to mediate some of the immunologic ‘defects’ associated with chronic lymphatic filariasis. While the clinical manifestations vary slightly depending on the specific lymph-dwelling filariae, the most consequential manifestations of lymphatic filariasis include lymphedema, elephantiasis, and hydrocele each related to dilatation of or inflammatory damage to the afferent and efferent lymphatics where the adult worms are typically localized [3].
The schistosomes are the causative agents of schistosomiasis that affects ~300 million people worldwide [4]. This parasite infects its human host through the skin when individuals come in contact with the cercarial-contaminated fresh water. Common symptoms are largely related to the granulomatous response to the schistosome eggs [5]. Schistosomes, like the filariae, can survive within the host without inducing serious disease symptoms, and adult worms are estimated to be able to survive for up to 40 years, with each worm producing 300–3,500 eggs per day. Its chronic nature is explained by the pro- and anti-inflammatory responses that are vital to the containment of immune-mediated damage to tissue [6, 7].
The chronicity, disability, social impact, and overall burden of these worm infections have led to much research on the immune responses and of pathogenesis of these infections. Specifically, studying the roles of both innate and adaptive branches of the immune response has focused on the mechanism of pathogen recognition, and studies in endemic areas suggest both innate and adaptive immune systems play a role in host defense.
Antigen presenting cells (APCs) play a major role in the innate immune responses in that they are capable of recognizing a wide range of molecular patterns expressed on pathogens, commonly known as pathogen-associated molecular patterns (PAMPs). In recent years, it has been shown that APCs recognize these PAMPS through Toll-like Receptors (TLRs) and NOD-like receptors (NLRs) leading to signaling [8, 9] through pathways that induce production of inflammatory cytokines. Understanding how recognition of these helminth parasites through the TLR pathway is paramount if the host-parasite interface is to be elucidated.
TLR structure
The function of TLRs is to recognize non-self molecules through recognition of PAMPs found on a variety of microorganisms including bacteria, fungi, and viruses. TLRs are type-1 transmembrane proteins that are pattern recognition receptors (PRRs) that function as sensors for innate immune responses that, in turn, direct the responses of the adaptive immune system. This innate immune response can be thought of as an early defense system that can recognize conserved motifs among molecules found in both animals and plants. The TLRs are evolutionarily conserved molecules and were identified by their homology to Toll, a molecule in Drosophila melanogaster that induces production of an antimicrobial protein [10].
TLRs are expressed on many cells of the immune system, in different combinations, at cell surface and endosome membrane of cells such as dendritic cells (DCs), macrophages, neutrophils, endothelial cells, and lymphocytes. This cell-specific but differential pattern of expression is one mechanism to ensure a more diverse response to different types of pathogens.
Mammalian species typically have 10 to 13 distinct TLRs that recognize conserved PAMPS, 10 of which are found in humans [11]. Mammalian TLRs have been characterized based on stimulation patterns by different ligands in vitro (reviewed in [12]). Due to the heterogeneity of the extracellular domains of TLRs, a variety of ligands are recognized by specific TLRs (Table 1). The extracellular domains of TLRs contain variations of 18–31 leucine-rich repeats [11]. Commonly TLRs associate into homodimers with the exception of TLR2, which preferentially forms a heterodimer with either TLR1 or TLR6 (reviewed in [13]). Pathogen-encoded TLR ligands are divided into three categories: lipids and lipopeptide (TLR2/TLR1; TLR2/TLR6; TLR4), nucleic acids (TLR3, TLR7, TLR8, TLR9), and proteins (TLR5 and, in mice, TLR11). The ligand for TLR10 has not been yet identified (see Table 1; reviewed in ref. [14]).
TLR signaling
The binding of TLRs triggers a series of signaling events that lead to the activation of the nuclear factor-κB (NF-κB) pathway and, as a result, induction of inflammatory responses. TLRs have a common conserved domain (TIR) that is located intracellularly. Once this Toll/IL-1R (TIR) domain is activated, it initiates a signal through five different adaptor molecules that eventually leads to activation of the NF-κB-dependent pathway along with the interferon regulatory factor (IRF) pathway (reviewed in [13]).
After interaction with a specific ligand, the TLR recruits an adaptor protein to its TIR domain. The first discovered adaptor molecule was myeloid differentiation primary response gene 88 (MyD88), a molecule involved in the signaling pathway for all TLRs except TLR3. MyD88 contains a death domain at its N-terminus and a TIR domain at its C-terminus. It often couples with MyD88 adaptor-like (MAL) protein for certain TLR signaling. Another adaptor protein, TIR-related adaptor protein inducing interferon (TRIF), is the sole adaptor molecule for TLR3 that signals through a MyD88-independent pathway. TRIF interacts with adaptor molecule TRIF-related adaptor molecule (TRAM) for signaling through TLR4, which also can signal through the MAL/MyD88 adaptor protein complex (reviewed in ref. [13]). Activation through TLR4 by LPS, for example, induces production of proinflammatory cytokines IL-6, TNF-α, and IL-12 [15]. Through the MyD88-independent pathway, TLR4 can induce activation of IRF3 and induce production of IFN-α/β through the TRAM/TRIF complex [16–18].
NF-κB and MAPK are involved in the downstream affects of TLR signaling pathways. NF-κB is a major regulator of gene transcription made up of five subunits: p50, p65, p52, RelB, and c-Rel (reviewed in [19]). Two of these subunits dimerize to allow translocation into the nucleus, and NF-κB binds to DNA. Once in the nucleus, NF-κB regulates the production of more than 150 genes coding for cytokines, Ag receptors, apoptosis, and host defense. Both sensory and effector functions of TLRs are involved during immune response to pathogens. The production of proinflammatory cytokines and increased APC costimulatory potential are perhaps the immediate response of the host to pathogens by the host via TLR recognition of that particular pathogen [20].
TLR activation by helminth parasites
Downregulation of an Ag-specific T cell proliferative response is a hallmark of several different parasitic infections [21–23] and may reflect a mechanism by which parasite survival is promoted in the host. Factors such as regulatory cytokines [24], altered function of APC [25–30], T cell apoptosis [31], and inducible NO synthase [22, 32] have each been implicated in mediating this downregulated response. We have previously shown that microfilarial antigen (MF Ag) as well as live microfilaria (MF) exhibit a suppressive effect on DCs. For example, they impair production of both IL-12 and IL-10 by DCs [27, 28]. Furthermore, the infective stage (L3) of B. malayi also downregulates the function of human Langerhans’ cells (LCs), leading to a decreased proliferation of CD4+ T cells that encounter these parasite-exposed LCs [29].
Although there have been many studies examining TLR signaling in response to intracellular pathogens (including the parasitic protozoa) [33–35], fewer studies have examined interaction of the multicellular helminth parasites and the TLR system. The mechanisms underlying inflammation induced by filarial infection are not fully understood.
The observation that W. bancrofti, B. malayi, and Onchocerca volvulus harbor an obligate intracellular rickettsia-like Wolbachia bacteria [36–38] has raised the possibility that filarial-infected individuals may respond to this endosymbiont in a manner that promotes or initiates an inflammatory response [39–43]. In fact, the evidence that filarial parasites elicit immune response through TLRs originally came from a study by Taylor et al. [44] indicating that Wolbachia extracts derived from a mosquito cell line induced similar LPS-dependent response in murine macrophages, perhaps through TLR4. Furthermore, in 2004, Brattig et al. [45] advanced these studies by showing that the major surface protein of Wolbachia (wsp) in filarial nematodes can indeed elicit immune response in human embryonic kidney 293 (HEK293) cell line through both TLR2 and TLR4. In the same study, these investigators also showed that wsp induced an inflammatory response measured by proinflammatory cytokines in murine macrophages and DCs again through a TLR2- and TLR4-dependent mechanism, as mice deficient in either of these TLRs failed to elicit the same response. These studies were further pursued by Hise et al. [46] using human TLR-transfected HEK cell line as well as murine macrophages from TLR and adaptor molecule gene knockout to show that the inflammatory response to Wolbachia is mediated primarily by engagement of TLR2 and TLR6 and is indeed dependent on MyD88 and the TIR domain-containing adaptor protein (TIRAP)/MAL.
Major secreted products (ES) also contribute to the immunomodulatory response seen in helminth infections. In the rodent filarial nematode Acanthocheilonema viteae, the phosphorylcholine-containing glycoprotein ES-62 was found to inhibit the activation of B and T lymphocytes through TLR recognition. Using mice deficient in TLR4 or MyD88, Goodridge et al. were able to show that the effect of ES-62 on IL-12 and TNF-α production was mediated by an MyD88-dependent TLR4 pathway [47]. Furthermore, utilizing human embryonic kidney 293 (HEK293) cells, we have shown that live mf of B. malayi can activate TLR2 directly, but not TLR4 or TLR3 [48].
Immune deviation during S. mansoni infection is characterized by an alteration in the number and activation state of many cell types including macrophages and DC [4]. During this infection, the immune response is initially Th1-like but, following the onset of egg production, this response becomes highly Th2 polarized. After the release of eggs by this parasite, a profound granulomatous remodeling response driving the production of IL-4 and IL-13 is observed [49]. The primary inducer of this Th2 response that characterizes schistosomiasis [50, 51] is known to be both complex carbohydrates ([52] ,Yazdanbaksh, M (published and unpublished)) expressed on the soluble egg Ag (SEA) secreted by S. mansoni ova and parasite egg secreted ribonuclease (Jankovic, D, unpublished). Tissue-resident macrophages play an important role during the course of this infection by producing cytokines, chemotactic factors, and free radicals [53–55]. Furthermore, with chronic Th2-like conditions seen in schistosome infections, a subset of macrophages undergoes an alternative activation [56] that may mediate the tissue-destructive fibrotic response seen most commonly in the liver. Indeed, it has been documented that bone marrow-derived macrophages from mice with S. mansoni egg-induced pulmonary granulomas have an augmented response to TLR2 and TLR3 activation compared to control mice [57]. Furthermore, when live schistosome larvae of different maturation stages or soluble preparations from whole larvae were used to stimulate cytokine production by thioglycollate-elicited macrophages (tMφ), the parasite-derived molecules released from the schistosome larvae were shown to partly act through TLR4, MyD88-dependent pathway [58].
In addition to macrophages, signals delivered by DC can greatly influence Th polarization in the course of S. mansoni infection [59, 60] in that DCs, in general, use PRRs to identify and respond to the pathogens and produce a series of positive and negative signals involved in effector cell differentiation of naïve T cells [61, 62]. Although the schistosomal PAMPs, lysophosphatidylserine, and schistosomal glycolipids [63, 64] have been shown incapable of transducing a signal through TLRs on HEK-transfected cell lines, lysophosphatidylserine was found to activate DC through TLR2 in such a way that resulted in skewing toward a Th2 response and toward the development of Tregs [63]. Studies by Layland et al. [65] extended the link between triggering of TLR2 and the induction of Tregs, a finding that suggested that pathology induced in schistosomiasis could be mediated by TLR2-activated cells that resulted in Treg expansion.
Other studies have also indicated the activation of TLRs by this parasite, as they have shown that the eggs of S. mansoni can activate transcription of genes including cell surface markers CD40 and CD86, and cytokines IFN-β, TNF-α, and IL-12-p40 in mouse myeloid DCs [66]. Of interest, schistosome eggs can activate TLR2 (but not TLR4), and the dsRNAs from these eggs activate TLR3 in transfection assays [67].
TLR regulation by helminth parasites
Once activated by microbial PAMP, TLRs transduce signals through two pathways involving distinct adaptor proteins containing TIR domains discussed above. The end result of TLR signaling is activation of NF-κB, triggering induction of proinflammatory cytokines or IRF-dependent induction of type I interferons. TLR-dependent proinflammatory cascades triggered by infections with protozoan parasites and other microbial agents must be tightly regulated to avoid severe pathology or even mortality. Furthermore, this TLR regulation can be at the level of expression, function, or combination of the two, resulting in tight control of the immune response. We review below the regulation of expression and function of TLRs by these parasitic helminths (also see Table 2).
TLR expression
Although bacterial (and non-bacterial intracellular) pathogens typically cause increases in TLR expression, downregulation of TLR expression appears to be an important evasion strategy utilized successfully by some bacterial pathogens (reviewed in [68]). For example, a mechanism of bacteria-induced immune suppression has been suggested based on TLR4 downregulation and tolerance by LPS and TLR2 downregulation by bacterial lipoprotein [69, 70]. Similarly, protozoan parasites such as Entamoeba histolytica and Trypanosoma spp. have been shown to inhibit immune responses by suppressing TLR-mediated signaling [71, 72], particularly by downregulating TLR2 expression [73].
Direct evidence that multicellular helminths can downregulate the gene or protein expression of TLRs in human came from studies [48] that demonstrated that exposure of monocyte-derived DC to live MF of B. malayi significantly downregulated mRNA expression of TLR3, TLR4, TLR5, and TLR7. Furthermore, using immunoblot analysis TLR3 protein expression induced by Brugian parasites was shown to be unaltered, while the protein expression of TLR4 was markedly diminished.
In clinical settings, Babu et al. [74] have shown that filaria-infected individuals indeed have decreased expression of TLR1, TLR2, TLR4, and TLR9 on B cells based both on mRNA expression and protein (surface or intracellular expression) levels. They also showed that filarial infected individuals had a diminished ability to upregulate TLR expression upon parasite Ag stimulation in both B cells and monocytes. Other studies have also shown diminished surface expression of TLR after exposure of murine macrophages to B. malayi female worm extracts (BMFE) [75].
One characteristic of lymphatic filarial infection is a modulated Ag-driven Th1 response [3] and the major adaptive immune response critical for elimination of the most pathogens. Previous studies have shown that exposure to MF results in a diminished ability of APCs to stimulate CD4+ T cells [27, 28]. Diminished T cell activation would naturally have a profound effect on the ability of the adaptive immune system to fulfill its role. It has also been reported that T cells express many of the TLRs at the mRNA gene level and therefore may play an additional role in TLR signaling. T cells from patients with lymphatic filariasis, in the presence of B cells and monocytes, expressed significantly lower levels of TLR1, 2, and 4 than did T cells from filarial-uninfected individuals [76] suggesting that filarial parasites (and presumably other helminth parasites) can affect T cell development.
TLR function
Regulation of TLRs can be manipulated by helminth parasites at the level of TLR expression and function. We have recently shown that not only do live MF of B. malayi downregulate the mRNA expression of TLR3 and TLR4 in human monocyte-derived DC, they also diminish the response of these cells to TLR3 and TLR4 ligands. DCs that were exposed to live MF for 48 h had a significant decrease in production of IL-12p40 following activation with poly I:C or LPS, and IFN-α, IL-12 p40, IL-12 p70, and MIP-1α following activation with poly I:C. Moreover, the mRNA and protein expression of MyD88 was significantly decreased in DCs that were exposed to live MF. Notably, mRNA expression of inhibitory molecules such as SOCS1 and SOCS3 were upregulated in these MF-exposed cells. Finally, live MF downregulated the binding ability of p50 and p65 (of the NF-κB complex) in DC following activation with either LPS or poly I:C, which may, in turn, explain the diminished cytokine production by these cells [48]. The possibility that parasitic helminths may bind particular TLRs but not signal has been given credence in murine studies by Goodridge et al. [47] in which ES-62 of the filarial nematode Acanthocheilonema vitiae, induces by itself low production of IL-12 and TNF-α in a TLR4- and MyD88-dependent manner but also leads to subsequent inhibition of cytokines (IL-12, TNF-α, and IL-6) production induced by the TLR4 ligand LPS.
In a study by Babu et al. [74], in which the expression of several TLRs was shown to be lower in filaria-infected compared to filarial-uninfected individuals, the response to specific TLR ligands was also diminished; the diminished cytokine production appeared to reflect chronic exposure to filarial parasites causing diminished ability to signals through TLRs [74].
In studies with the obligate intracellular endosymbiont Wolbachia of Brugia malayi, Turner et al. [75] suggested a role for Wolbachia in promoting macrophage tolerance to TLR through a TLR2/MyD88 pathway. This study revealed that pre-exposure of murine macrophages to BMFE inhibited production of TNF-α and IL-12 in response to secondary stimulation by the worm, ligands for TLR2, TLR4, and TLR9 and through a TLR3-mediated but MyD88-independent process. Interestingly, this BMFE-mediated heterotolerance of macrophages was abrogated in the absence of MyD88 and TLR2 but not TLR4, suggesting a direct role of TLR2 in this system [75].
The negative regulatory effect of helminth parasites also applies to SEA. For example, it has become apparent that SEA exerts an inhibitory effect on DC maturation induced by TLR ligands in that DCs pulsed with both SEA and LPS produce less IL-12 than DCs pulsed only with the TLR ligand alone [77, 78]. Furthermore, SEA has been shown to inhibit the ability of CpG, poly I:C, hyaluronic acid, and LPS to induce IL-12 production or upregulate CD80, CD86, and MHC class II surface expression on DCs [79]. Also, SEA has been shown to prevent LPS-induced downregulation of other genes based on microarray analysis [79]. This suppressive effect extends to human DCs; SEA has been shown to suppress maturation of human DCs induced by both poly I:C and LPS as indicated by a decrease in both cytokine production (IL-12, IL-6, and TNF-α) and by costimulatory molecule (CD80/86) surface expression [80]. In addition, SEA suppressed Th1 responses following coculture of poly I:C-pulsed DCs and T cells, and shaped the LPS-induced responses toward a Th2 response.
Interestingly, cells from Schistosoma haematobium (Sh)-infected children in Gabon had a lower level of cytokine responses to a schistosomal phosphatidylserine fraction containing a TLR2 ligand as well as to a TLR4 ligand as compared with Sh-uninfected children [81]. In contrast, uninfected children had a higher response to schistosomal adult worm glycolipids (none being TLR ligands) than did infected children. These data suggest that chronic and presumably continuous exposure to helminth antigens can negatively regulate the response of cells to PAMPs that are derived from these parasites and change the immune response in helminth-infected individuals.
Concluding remarks
TLRs have many modes of action that allow them to play an important role in the immune response to pathogens. Each TLR clearly has a unique role in generating that response. The chronic nature of the two systemic helminth infections described in this review provides a window into mechanisms used by the parasite to subvert the host immune system, most notably by interfering with both the expression and function of TLRs.
The fact that helminth parasites can both activate (to a small degree) and negatively regulate TLRs (to a much larger degree) suggests that the immune response to invasive helminths is under tight control. Perhaps the timing of this early activation and subsequent regulation is important for the individuals infected with these parasites. However, because exposure to helminth parasites (and their antigens) is prolonged, the function of the cells involved in innate immune responses is dampened. This negative regulation of TLRs results in diminished pro-inflammatory cytokine production that may be protective to the host by preventing pathology. Compromised TLR expression and function, however, can have bystander effects such that response to non-helminth pathogens (e.g., bacteria or viruses) is also dampened. Thus, exploring the interface between tissue-invasive helminth parasites and the innate immune system should shed additional light onto the role played by TLR dysregulation and provide new areas of study for therapy and vaccine development that may involve alterations in TLR expression and function.
References
Mencl F, Birkle M, Blanda M, Gerson LW. EMTs’ knowledge regarding transmission of infectious disease. Prehosp Emerg Care. 2000;4:57–61.
Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites–masters of regulation. Immunol Rev. 2004;201:89–116.
Nutman TB, Kumaraswami V. Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India. Parasite Immunol. 2001;23:389–99.
Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2:499–511.
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. 2007;85(2):148–54.
Wynn TA, Cheever AW, Williams ME, Hieny S, Caspar P, Kuhn R, et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol. 1998;160:4473–80.
Boros DL. The role of cytokines in the formation of the schistosome egg granuloma. Immunobiology. 1994;191:441–50.
Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from Toll-like receptors. Science. 2004;304:1014–8.
Mariathasan S, Monack DM. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol. 2007;7:31–40.
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394–7.
Means TK, Golenbock DT, Fenton MJ. The biology of Toll-like receptors. Cytokine Growth Factor Rev. 2000;11:219–32.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.
Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511.
Barrat FJ, Coffman RL. Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol Rev. 2008;223:271–83.
Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 2002;420:324–9.
Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003;301:640–3.
Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, et al. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J Exp Med. 2003;198:1043–55.
O’Neill LA, Fitzgerald KA, Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 2003;24:286–90.
Delhalle S, Blasius R, Dicato M, Diederich M. A beginner’s guide to NF-κB signaling pathways. Ann N Y Acad Sci. 2004;1030:1–13.
Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med. 2007;13:552–5.
Candolfi E, Hunter CA, Remington JS. Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect Immun. 1994;62:1995–2001.
Dai WJ, Gottstein B. Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection. Immunology. 1999;97:107–16.
Schleifer KW, Mansfield JM. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol. 1993;151:5492–503.
King CL, Mahanty S, Kumaraswami V, Abrams JS, Regunathan J, Jayaraman K, et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest. 1993;92:1667–73.
Loke P, MacDonald AS, Robb A, Maizels RM, Allen JE. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol. 2000;30:2669–78.
Whelan M, Harnett MM, Houston KM, Patel V, Harnett W, Rigley KP. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J Immunol. 2000;164:6453–60.
Semnani RT, Sabzevari H, Iyer R, Nutman TB. Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun. 2001;69:5813–22.
Semnani RT, Liu AY, Sabzevari H, Kubofcik J, Zhou J, Gilden JK, et al. Brugia malayi microfilariae induce cell death in human dendritic cells, inhibit their ability to make IL-12 and IL-10, and reduce their capacity to activate CD4+ T cells. J Immunol. 2003;171:1950–60.
Semnani RT, Law M, Kubofcik J, Nutman TB. Filaria-induced immune evasion: suppression by the infective stage of Brugia malayi at the earliest host-parasite interface. J Immunol. 2004;172:6229–38.
Semnani RT, Keiser PB, Coulibaly YI, Keita F, Diallo AA, Traore D, et al. Filaria-induced monocyte dysfunction and its reversal following treatment. Infect Immun. 2006;74:4409–17.
Jenson JS, O’Connor R, Osborne J, Devaney E. Infection with Brugia microfilariae induces apoptosis of CD4+ T lymphocytes: a mechanism of immune unresponsiveness in filariasis. Eur J Immunol. 2002;32:858–67.
Mabbott NA, Sutherland IA, Sternberg JM. Suppressor macrophages in Trypanosoma brucei infection: nitric oxide is related to both suppressive activity and lifespan in vivo. Parasite Immunol. 1995;17:143–50.
Zhang G, Ghosh S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem. 2002;277:7059–65.
Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J Immunol. 2001;167:2193–201.
Shapira S, Harb OS, Caamano J, Hunter CA. The NF-κB signaling pathway: immune evasion and immunoregulation during toxoplasmosis. Int J Parasitol. 2004;34:393.
Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet. 2000;355:1242–3.
Bandi C, Trees AJ, Brattig NW. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases. Vet Parasitol. 2001;98:215–38.
Bazzocchi C, Jamnongluk W, O’Neill SL, Anderson TJ, Genchi C, Bandi C. wsp gene sequences from the Wolbachia of filarial nematodes. Curr Microbiol. 2000;41:96–100.
Punkosdy GA, Addiss DG, Lammie PJ. Characterization of antibody responses to Wolbachia surface protein in humans with lymphatic filariasis. Infect Immun. 2003;71:5104–14.
Punkosdy GA, Dennis VA, Lasater BL, Tzertzinis G, Foster JM, Lammie PJ. Detection of serum IgG antibodies specific for Wolbachia surface protein in rhesus monkeys infected with Brugia malayi. J Infect Dis. 2001;184:385–9.
Brattig NW. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes Infect. 2004;6:113–28.
Brattig NW, Büttner DW, Hoerauf A. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect. 2001;3:439–46.
Taylor MJ, Bandi C, Hoerauf AM, Lazdins J. Wolbachia bacteria of filarial nematodes: a target for control? Parasitol Today. 2000;16:179–80.
Taylor MJ, Cross HF, Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med. 2000;191:1429–36.
Brattig NW, Bazzocchi C, Kirschning CJ, Reiling N, Büttner DW, Ceciliani F, et al. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol. 2004;173:437–45.
Hise AG, Daehnel K, Gillette-Ferguson I, Cho E, McGarry HF, Taylor MJ, et al. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol. 2007;178:1068–76.
Goodridge HS, Marshall FA, Else KJ, Houston KM, Egan C, Al-Riyami L, et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol. 2005;174:284–93.
Semnani RT, Venugopal PG, Leifer CA, Mostbock S, Sabzevari H, Nutman TB. Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites. Blood. 2008;112:1290–8.
Wynn TA. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol. 2004;4:583–94.
Chensue SW, Terebuh PD, Warmington KS, Hershey SD, Evanoff HL, Kunkel SL, et al. Role of IL-4 and IFN-γ in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. Orchestration, relative contribution, and relationship to macrophage function. J Immunol. 1992;148:900–6.
Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol. 1993;151:1430–40.
Okano M, Satoskar AR, Nishizaki K, Harn DA Jr. Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol. 2001;167:442–50.
Lukacs NW, Strieter RM, Shaklee CL, Chensue SW, Kunkel SL. Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation. Eur J Immunol. 1995;25:245–51.
Chensue SW, Ruth JH, Warmington K, Lincoln P, Kunkel SL. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J Immunol. 1995;155:3546–51.
Lukacs NW, Strieter RM, Lincoln PM, Brownell E, Pullen DM, Schock HJ, et al. Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. J Immunol. 1996;156:3945–51.
Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23–35.
Joshi AD, Raymond T, Coelho AL, Kunkel SL, Hogaboam CM. A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists. J Leukoc Biol. 2008;83:314–24.
Jenkins SJ, Hewitson JP, Ferret-Bernard S, Mountford AP. Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and -independent pathways. Int Immunol. 2005;17:1409–18.
Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3:984–93.
Pearce EJ, Kane CM, Sun J. Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response. Chem Immunol Allergy. 2006;90:82–90.
Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677–88.
Reinhardt RL, Kang SJ, Liang HE, Locksley RM. T helper cell effector fates–who, how and where? Curr Opin Immunol. 2006;18:271–7.
van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem. 2002;277:48122–9.
Van der Kleij D, Van Remoortere A, Schuitemaker JH, Kapsenberg ML, Deelder AM, Tielens AG, et al. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1–4(Fuc alpha 1–2Fuc alpha 1–3)GlcNAc. J Infect Dis. 2002;185:531–9.
Layland LE, Rad R, Wagner H, da Costa CU. Immunopathology in schistosomiasis is controlled by antigen-specific regulatory T cells primed in the presence of TLR2. Eur J Immunol. 2007;37:2174–84.
Trottein F, Pavelka N, Vizzardelli C, Angeli V, Zouain CS, Pelizzola M, et al. A type I IFN-dependent pathway induced by Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an inflammatory signature. J Immunol. 2004;172:3011–7.
Aksoy E, Zouain CS, Vanhoutte F, Fontaine J, Pavelka N, Thieblemont N, et al. Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem. 2005;280:277–83.
Alvarez JI. Inhibition of Toll like receptor immune responses by microbial pathogens. Front Biosci. 2005;10:582–7.
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000;164:3476–9.
Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, Kusumoto S, et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol. 2001;13:1595–9.
Brodskyn C, Patricio J, Oliveira R, Lobo L, Arnholdt A, Mendonca-Previato L, et al. Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect Immun. 2002;70:3736–43.
Ropert C, Gazzinelli RT. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi. J. Endotoxin Res. 2004;10:425–30.
Maldonado C, Trejo W, Ramirez A, Carrera M, Sanchez J, Lopez-Macias C, et al. Lipophosphopeptidoglycan of Entamoeba histolytica induces an antiinflammatory innate immune response and downregulation of Toll-like receptor 2 (TLR-2) gene expression in human monocytes. Arch Med Res. 2000;31:S71–3.
Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. J Immunol. 2005;175:1170–6.
Turner JD, Langley RS, Johnston KL, Egerton G, Wanji S, Taylor MJ. Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88/TLR2-dependent manner. J Immunol. 2006;177:1240–9.
Babu S, Blauvelt CP, Kumaraswami V, Nutman TB. Diminished T cell TLR expression and function modulates the immune response in human filarial infection. J Immunol. 2006;176:3885–9.
Cervi L, MacDonald AS, Kane C, Dzierszinski F, Pearce EJ. Dendritic cells co-pulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol. 2004;172:2016–20.
Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol. 2003;33:1439–49.
Kane CM, Cervi L, Sun J, McKee AS, Masek KS, Shapira S, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol. 2004;173:7454–61.
van Liempt E, van Vliet SJ, Engering A, Garcia Vallejo JJ, Bank CM, Sanchez-Hernandez M, et al. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol Immunol. 2007;44:2605–15.
van der Kleij D, van den Biggelaar AH, Kruize YC, Retra K, Fillie Y, Schmitz M, et al. Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J Infect Dis. 2004;189:1044–51.
Acknowledgments
This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. We thank NIAID intramural editor Brenda Rae Marshall for assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Because the authors are government employees and this is a government work, the work is in the public domain in the United States. Notwithstanding any other agreements, the NIH reserves the right to provide the work to PubMedCentral for display and use by the public, and PubMedCentral may tag or modify the work consistent with its customary practices. You can establish rights outside of the U.S. subject to a government use license.
Rights and permissions
About this article
Cite this article
Venugopal, P.G., Nutman, T.B. & Semnani, R.T. Activation and regulation of Toll-Like Receptors (TLRs) by helminth parasites. Immunol Res 43, 252–263 (2009). https://doi.org/10.1007/s12026-008-8079-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-008-8079-0